Puleva Biotech Report issue

For profit Phase 1 Phase 3
Founded: Granada Spain (1974)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2006
NCT00724204
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Department of Nutrition and Health. Puleva Biotech. Granada | Department of Nutrition and Helath. Puleva Biotech. Granada

Active Ingredients

Drugs in Phase 3 Trials (2)

fish oil (Omegavan) (1 trial)

lactobacillus fermentum (1 trial)

Drugs in Phase 1 Trials (1)

lactobacillus salivarius (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 3)

Infections (Phase 3)

Inflammation (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3